Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ISRCTN16425757) titled 'Deferred registration - Klear Bio Code: KLR003-Clin-004' on Oct. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date
Purpose: Treatment
Primary Sponsor: Klear Bio, Inc.
Condition:
The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date
Other
Intervention:
The Health Research Authority has approved...